Pancreatic Cancer Research

ResearcherHospital Del MarActive in the last 2 years

Judith Vinaixa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1991-9546; OpenAlex author ID A5034758609. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells. Co-author DOI 10.1073/pnas.2424051122↗
  2. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. Co-author DOI 10.1073/pnas.1722434115↗
  3. Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy. First author DOI 10.3390/cancers10010006↗
  4. The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer. Co-author DOI 10.18632/oncotarget.10199↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Neus Martínez‐Bosch · 4 shared papers, 2016–2025 · strength 0.46
  2. Pilar Navarro · 4 shared papers, 2016–2025 · strength 0.46
  3. Martín E. Fernández-Zapico · 2 shared papers, 2018–2025 · strength 0.27
  4. Noemí Manero‐Rupérez · 1 shared paper, 2025 · strength 0.20
  5. Renzo Emanuel Vera · 1 shared paper, 2025 · strength 0.20
  6. Patricia Santofimia‐Castaño · 1 shared paper, 2025 · strength 0.20
  7. David R Pease · 1 shared paper, 2025 · strength 0.20
  8. Juan Iovanna · 1 shared paper, 2025 · strength 0.20
  9. Carlos A. Orozco Castaño · 2 shared papers, 2016–2018 · strength 0.12
  10. Pedro Enrique Guerrero · 2 shared papers, 2016–2018 · strength 0.12
  11. Rosa F. Hwang · 1 shared paper, 2018 · strength 0.07
  12. Carmen E. Guerra · 1 shared paper, 2018 · strength 0.07
  13. Cristina Fillat Fonts · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.